1. Hansson G. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engi Med. 2005;352:1685–95.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–41.
3. Libby P, Theroux P. Pathophysiology of Coronary Artery Disease. Basic Sci Clin. 2005;111:3481–8.
4. Park K, Park WJ. Endothelial Dysfunction : Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. Cardiovasc Disord. 2015;30:1213–25.
5. Cahill PA, Redmond EM. Vascular endothelium e Gatekeeper of vessel health. Atherosclerosis. 2016;248:97–109.
6. Favero G, Paganelli C, Buffoli B, Rodella LF, Rezzani R. Endothelium and Its Alterations in Cardiovascular Diseases : Life Style Intervention. Biomed Res Int. 2014;2014.
7. Mudau M, Genis A, Lochner A, Strijdom H. Review Article Endothelial dysfunction : the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23(4):222–31.
8. Davignon J, Ganz P. Role of Endothelial Dysfunction in Atherosclerosis. Circulation. 2004;109:27–32.
9. Teixeira BC, Cauduro R, Macedo O, Correa CS, Ramis TR, Ribeiro JL, et al. Inflammatory markers , endothelial function and cardiovascular risk. J Vasc Bras. 2014;13(2):108–15.
10. Moriya J. Critical roles of inflammation in atherosclerosis. J Cardiol. 2018;1688:6.
11. Celermajert DS. Testing for endothelial dysfunction. Ann Med. 2000;293–304.
12. Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, et al. ZO-1 controls endothelial adherens junctions, cell–cell tension, angiogenesis, and barrier formation. J Cell Biol. 2015;208(6):821–38.
13. Goncharov N V, Nadeev AD, Jenkins RO, Avdonin P V. Review Article Markers and Biomarkers of Endothelium : When Something Is Rotten in the State. Oxid Med Cell Longev. 2017;2017.
14. Liu Y, Woodard PK. Chemokine receptors : Key for molecular imaging of inflammation in atherosclerosis. J Nucl Cardiol. 2018;26(4):1179–81.
15. Szentes V, Gazdag M, Szokodi I, Dézsi CA. The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction. Front Immunol. 2018;9(August):1932.
16. Szentes V, Gazdag M, Szokodi I, Dézsi CA. The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction. Front Immunol. 2018;9(August):1–8.
17. Reynders N, Abboud D, Baragli A, Noman MZ, Rogister B, Niclou SP, et al. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment. cells. 2019;8(613):1–17.
18. Altara R, Manca M, Brandao RD, Zeidan A, Booz GW, Zouein FA. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases. Clin Sci. 2016;130(7):463–78.
19. Murdoch C, Monk PN, Finn A. CXC CHEMOKINE RECEPTOR EXPRESSION ON HUMAN ENDOTHELIAL CELLS. Cytokine. 1999;11(9):704–12.
20. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real- Time Quantitative PCR and the 2 Ϫ ⌬⌬ C T Method. METHODS. 2001;408:402–8.
21. Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, et al. Autoimmunity Reviews From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 2010;9(12):830–4.
22. García-lópez MÁ, Sánchez-madrid F, Rodríguez-frade JM, Mellado M, Acevedo A, García MI, et al. CXCR3 Chemokine Receptor Distribution in Normal and Inflamed Tissues : Expression on Activated. Lab Investig. 2001;81(3):409–18.
23. Gimbrone Jr M, García-Cardeña G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2017;118(4):620–36.
24. Zhu X, Zou Y, Wang B, Zhu J. Blockade of CXC chemokine receptor 3 on endothelial cells protects against sepsis-induced acute lung injury. J Surg Res. 2016;6(May):1–9.
25. Billottet C, Quemener C, Bikfalvi A. CXCR3, a double-edged sword in tumor progression and angiogenesis. BBA - Rev Cancer. 2013;
26. Wang H, Li J, Zhong P, Wang S, Zhang L, Yang R, et al. Blocking CXCR3 with AMG487 ameliorates the blood-retinal barrier disruption in diabetic mice through anti-oxidative. Life Sci. 2019;228(January):198–207.
27. Wang X, Zhao Z, Zhu K, Bao R, Meng Y, Bian J, et al. Effects of CXCL4/CXCR3 on the lipopolysaccharide-induced injury in human umbilical vein endothelial cells. J Cell Physiol. 2019;234(12):22378–85.
28. Wu Q, Dhir R, Wells A. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol Cancer. 2012;11:1–16.
29. Zhou Z, Connell MC, MacEwan DJ. TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal. 2007;19(6):1238–48.
30. Ledebur H, Parks T. Transcriptional Regulation the Intercellular Adesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells. Biol Chem. 1995;2(13):933–43.
31. Timmerman I, Daniel AE, Kroon J, Van Buul JD. Leukocytes Crossing the Endothelium: A Matter of Communication. Int Rev Cell Mol Biol. 2016;322:281–329.
32. Visser J, Rozing J, Sapone A, Lammers A, Fasano A. Tight junctions PermeabilityIntestinal Celiac Autoimmunity. ann N Y Acd sci. 2010;195–205.
33. Berghoff SA, Düking T, Spieth L, Winchenbach J, Stumpf SK, Gerndt N, et al. Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model. Acta Neuropathol Commun. 2017;5(1):94.
34. Złotkowska A, Andronowska A. Chemokines as the modulators of endometrial epithelial cells remodelling. Sci Rep. 2019;9(1):1–9.
35. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170(2):191–203.